We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$470M
AUM Growth
+$58.6M
Cap. Flow
+$28.9M
Cap. Flow %
6.15%
Top 10 Hldgs %
52.54%
Holding
360
New
18
Increased
55
Reduced
45
Closed
16
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQJ icon
176
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.18B
$33K 0.01%
1,382
+2
+0.1% +$47
CE icon
177
Celanese
CE
$4.82B
$32K 0.01%
310
PAYC icon
178
Paycom
PAYC
$10B
$32K 0.01%
102
VEEV icon
179
Veeva Systems
VEEV
$37.4B
$32K 0.01%
201
TSM icon
180
TSMC
TSM
$2.18T
$31K 0.01%
421
+1
+0.2% +$72
CVX icon
181
Chevron
CVX
$366B
$30K 0.01%
165
-25
-13% -$4.36K
BURL icon
182
Burlington
BURL
$23.2B
$29K 0.01%
143
EZU icon
183
iShare MSCI Eurozone ETF
EZU
$9.91B
$29K 0.01%
+738
New +$27.6K
MCHP icon
184
Microchip Technology
MCHP
$46B
$29K 0.01%
408
NOC icon
185
Northrop Grumman
NOC
$81.2B
$29K 0.01%
54
NVO
186
Novo Nordisk
NVO
$209B
$29K 0.01%
422
AGG icon
187
iShares Core US Aggregate Bond ETF
AGG
$138B
$28K 0.01%
+285
New +$27.6K
ESGV icon
188
Vanguard ESG US Stock ETF
ESGV
$13.6B
$28K 0.01%
430
-220
-34% -$14.7K
GLD icon
189
SPDR Gold Trust
GLD
$141B
$28K 0.01%
166
DBC icon
190
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
$27K 0.01%
1,106
MRNA icon
191
Moderna
MRNA
$23.6B
$27K 0.01%
+150
New +$24.5K
TAN icon
192
Invesco Solar ETF
TAN
$1.49B
$27K 0.01%
374
KNSL icon
193
Kinsale Capital Group
KNSL
$8.51B
$26K 0.01%
+100
New +$28.8K
BLK icon
194
Blackrock
BLK
$176B
$25K 0.01%
35
IAU icon
195
iShares Gold Trust
IAU
$67.5B
$25K 0.01%
729
GSK icon
196
GSK
GSK
$106B
$24K 0.01%
685
NEA icon
197
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.42B
$24K 0.01%
2,078
UL icon
198
Unilever
UL
$136B
$24K 0.01%
427
VUG icon
199
Vanguard Morningstar Growth ETF
VUG
$231B
$24K 0.01%
666
BBBY
200
DELISTED
Bed Bath & Beyond Inc
BBBY
$24K 0.01%
9,600

Similar funds

Roble Belko & Company's Q4 2022 Portfolio in Review

As of Q4 2022, Roble Belko & Company held 360 positions worth $470M, up 14% from $412M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Roble Belko & Company deployed $28.9M of net new capital in Q4 2022, opening 18 new positions and adding to 55 existing holdings. Its largest new stake was Vanguard Total Bond Market: 152,338 shares worth $10.9M.

By sector, the portfolio is most concentrated in Real Estate at 2.4% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was iShares Ultra Short Duration Bond Active ETF, an estimated $7.77M trimmed.

  • Roble Belko & Company's largest Q4 2022 buy was Vanguard Total Bond Market: 152,338 shares worth $10.9M.
  • Roble Belko & Company added most to Vanguard Morningstar Total Stock Market ETF in Q4 2022, an estimated $6.86M increase.
  • Roble Belko & Company's biggest Q4 2022 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $7.77M.
  • Roble Belko & Company fully exited BlackRock Short Maturity Municipal Bond ETF in Q4 2022, selling an estimated $671K.
  • Roble Belko & Company's ten largest holdings make up 53% of its $470M portfolio in Q4 2022.
  • Roble Belko & Company opened 18 new positions and closed 16 in Q4 2022.
  • Roble Belko & Company's portfolio value rose 14% quarter-over-quarter to $470M.

Based on Roble Belko & Company's 13F filing for Q4 2022, filed 8 Feb 2023.